Could a Virtual Human Be Used to Explore Excessive Daytime

Total Page:16

File Type:pdf, Size:1020Kb

Could a Virtual Human Be Used to Explore Excessive Daytime Pierre Philip* Could a Virtual Human Be Used to Universite´ de Bordeaux CNRS USR-3413 Explore Excessive Daytime Bordeaux, France Sleepiness in Patients? and Clinique du Sommeil, CHU Pellegrin Bordeaux, France Ste´ phanie Bioulac Universite´ de Bordeaux Abstract CNRS USR-3413 Bordeaux, France Excessive daytime somnolence (EDS) is defined as the inability to stay awake in daily and life activities. Several scales have been used to diagnose excessive daytime sleepiness, Poˆle de Pe´dopsychiatrie the most widely used being the Epworth Sleepiness Scale (ESS). Sleep disorders and Universitaire EDS are very common in the general population. It is therefore important to be able Hoˆpital Charles Perrens to screen patients for this symptom in order to obtain an accurate diagnosis of sleep France disorders. Embodied Conversational Agents (ECA) have been used in the field of affective computing and human interactions but up to now no software has been spe- Alain Sauteraud cifically designed to investigate sleep disorders. We created an ECA able to conduct Universite´ de Bordeaux an interview based on the ESS and compared it to an interview conducted by a sleep CNRS USR-3413 specialist. We recruited 32 consecutive patients and a group of 30 healthy volunteers Bordeaux, France free of any sleep complaints. The ESS is a self-administered questionnaire that asks the subject to rate (with a pen and paper paradigm) his or her probability of falling asleep. Cyril Chaufton For the purpose of our study, the ECA or real-doctor questionnaire was modified as Universite´ de Bordeaux follows: Instead of the ‘‘I’’ formulate, questions were asked as ‘‘Do you.’’ Our software CNRS USR-3413 is based on a common 3D game engine and several commercial software libraries. It Bordeaux, France can run on standard and affordable hardware products. The sensitivity and specificity and of the interview conducted by the ECA were measured. The best results (sensibility Clinique du Sommeil, CHU Pellegrin and specificity >98%) were obtained to discriminate the sleepiest patients (ESS 16) Bordeaux, France but very good scores (sensibility and specificity >80%) were also obtained for alert subjects (ESS<8). ESS scores obtained in the interview conducted by the physician Je´ roˆ me Olive were significantly correlated with ESS scores obtained in the interview the ECA con- Universite´ de Bordeaux ducted. Most of the subjects had a positive perception of the virtual physician and con- CNRS USR-3413 sidered the interview with the ECA as a good experience. Sixty-five percent of the Bordeaux, France participants felt that the virtual doctor could significantly help real physicians. Our results show that a virtual physician can conduct a very simple interview to evaluate EDS with very similar results to those obtained by a questionnaire administered by a real physician. The expected massive increase in sleep complaints in the near future likely means that more and more physicians will be looking for computerized systems to help them to diagnose their patients. 1 Introduction Excessive daytime sleepiness (EDS) is defined as sleepiness that occurs in a situation when an individual would usually be expected to be awake and alert (Littner et al., 2005). This very disabling symptom, which is responsible for Presence, Vol. 23, No. 4, Fall 2014, 369–376 doi:10.1162/PRES_a_00197 ª 2015 by the Massachusetts Institute of Technology *Correspondence to [email protected]. Philip et al. 369 Downloaded from http://www.mitpressjournals.org/doi/pdf/10.1162/PRES_a_00197 by guest on 30 September 2021 370 PRESENCE: VOLUME 23, NUMBER 4 many traffic accidents (Philip, 2010), affects up to 19.5% bally and nonverbally. They can attract and maintain the of the general population in Western countries when attention of users in an interaction (Peters & Grandjean, subjective assessment is used (Ohayon, 2008, 2012). 2011), disambiguate written or spoken texts, and make This number is increasing owing to an increase in interactions more expressive and more socially adapted. chronic sleep deprivation in young people (Leger et al., ECAs can also control somewhat the communication of 2011) and an increase in obstructive sleep apnea in older their emotional states. They can display a large range of subjects (Norman & Loredo, 2008). Nevertheless, emotions (Arya, DiPaola, & Parush, 2009), such as dif- although EDS is becoming a real public health issue, ferent types of smiles (Ochs, Niewiadomski, Brunet, & very few physicians are trained to adequately differentiate Pelachaud, 2012). Emotions such as relief, embarrass- fatigue from EDS. Indeed fatigue, for which the treat- ment, anxiety, and regret can also be seen as sequences ment is rest, can be defined as a growing difficulty to per- of multimodal signals (Niewiadomski, Hyniewska, & form with a progressive decrease in performance. Sleepi- Pelachaud, 2011). In addition, several studies have ness, for which the treatment is sleep, is the difficulty in shown that when they use the vehicle of a humanoid remaining awake. face, human–machine interactions are perceived as being Both symptoms can alter performance but their causes similar to human–human interaction (Reeves & Nass, and treatments are radically different. This is a major 1996). The machine is perceived more as a socio-emo- issue because many patients suffering from sleep disor- tional actor than a tool (Reeves & Nass, 1996).This feel- ders are diagnosed as psychiatric patients (mood or anxi- ing is reinforced when the interface takes the form of an ety disorders) and therefore receive central nervous sys- ECA. tem drugs, which increase their level of sleepiness and ECAs have been used in a wide range of clinical appli- driving risk (Blazejewski, Girodet, Orriols, Capelli, & cations and they can act as therapists with whom human Moore, 2012; Orriols et al., 2011). patients can interact. The US Army has funded programs Several scales have been used to diagnose (Akerstedt to test the potential use of these software programs for & Gillberg, 1990; Hoddes, Zarcone, Smythe, Phillips, soldiers coming back from Iraq and suffering from post- & Dement, 1973) excessive or chronic daytime sleepi- traumatic stress disorder (PTSD) (Rizzo et al., 2009). ness, the most widely used being the Epworth Sleepiness They can also act as social companions to help teenagers Scale (ESS; Johns, 1991). This self-administered scale with substance abuse problems (Lisetti & Wagner, developed in the 1990s has been used in thousands of 2007). ECAs can also act as a patient seeking therapeutic studies and is the simplest way to self-evaluate EDS. assistance. Young practitioners interact with them to Sleep disorders are very common and EDS is a major learn how to interact with traumatic patients (Marsella, symptom associated with various sleep disorders such as Johnson, & LaBore, 2003). obstructive sleep apnea syndrome, restless legs syn- ECAs have been used in the field of affective comput- drome, and hypersomnias. It is therefore important to ing and human interactions (Garau, Slater, Pertaub, & be able to screen patients for this symptom in order to Razzaque, 2005) but up to now no software has been obtain an accurate diagnosis. specifically designed to investigate sleep disorders. Since Virtual reality has been used for clinical purposes for the ESS is the most widely validated scale to evaluate Ex- several years (Bioulac et al., 2012; Giroux et al., 2013) cessive Daytime Sleepiness (Johns, 2010), we hypothe- and there is a growing interest in Embodied Conversa- sized that although it was initially designed as a self- tional Agents (ECAs) to be used as a new type of administered questionnaire, it was a suitable model for human–machine interface (DeVault et al., 2013). ECAs assessing the ability of an ECA to investigate excessive aim to unite gesture, facial, and verbal expression to ena- daytime sleepiness. ble face-to-face communication with users, providing a We therefore created software (ECA) able to conduct strong means of human–system interaction. They are an interview based on the Epworth Sleepiness Scale autonomous entities that are able to communicate ver- (ESS) and compared it to an interview conducted by a Downloaded from http://www.mitpressjournals.org/doi/pdf/10.1162/PRES_a_00197 by guest on 30 September 2021 Philip et al. 371 sleep specialist. Our main objective was to assess the sen- asleep. The ESS refers to driving, watching TV, talking sitivity and specificity of ESS scores collected by the to someone, or reading in common daily life situations ECA. where sleepiness is explored. The answers for the eight In order to minimize the self-perceived differences questions are added together to obtain a single score. A between the ECA and the real physician, subjects did score in the 0–8 range is considered to be normal while a not know whether the ECA was operated by a human score above 11 indicates moderate to severe sleepiness, (Wizard of Oz) or by artificial intelligence software. suggesting that expert medical advice should be sought. We have shown that high ESS scores (>15) correlate 2 Methods with the risk of traffic accidents (Philip, 2010), and sev- eral studies have shown that treatment affecting daytime 2.1 Population alertness significantly lowers ESS scores (Hardinge, Pit- We recruited 32 consecutive patients (18 men and son, & Stradling, 1995). 14 women, mean age: 46.7 6 12.8) attending the Bor- The ESS (Johns, 1991) was originally created with the deaux sleep clinic for a consultation and a group of 30 intention of preserving the exact wording of the ques- healthy volunteers (8 men and 22 women, mean age: tionnaire so as to provide a standardized test and pre- 37.3 6 11.0) free of any sleep complaints. Subjects were serve its validity. Its author recommends that the admin- informed that they would have an interview with a vir- istrator of the questionnaire not discuss the results of the tual physician operated by an ECA and then a similar ESS with the subject until it is completed, as this may interview with a real physician.
Recommended publications
  • Physiological and Pharmacological Factors of Insomnia in HIV Disease
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Faculty Publications and Other Works -- Nursing Nursing January 1999 Physiological and pharmacological factors of insomnia in HIV disease Kenneth D. Phillips University of Tennessee - Knoxville, [email protected] Follow this and additional works at: https://trace.tennessee.edu/utk_nurspubs Part of the Critical Care Nursing Commons Recommended Citation Phillips, K. D. (1999). Physiological and pharmacological factors of insomnia in HIV disease. Journal of the Association of Nurses in AIDS Care, 10(5), 93-97. This Article is brought to you for free and open access by the Nursing at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Faculty Publications and Other Works -- Nursing by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Clinical Column JANACPhillips /Vol. Insomnia 10, No. and 5, September/OctoberHIV Disease 1999 Physiological and Pharmacological Factors of Insomnia in HIV Disease Kenneth D. Phillips, PhD, RN For almost two decades, HIV infection has been a Ungvarski, 1995), and the side effects of many antiret- progressive disease leading to early morbidity and roviral therapies and other drugs (Chohan, 1999) used mortality for more than a million Americans (Centers to treat HIV disease may produce insomnia. Although for Disease Control and Prevention [CDC], 1998). helping the client manage sleep disturbance is of great Although HIV infection strikes people of any age, it importance, available information in this area remains continues to be a disease of young persons in relatively modest. good health. Persons with HIV (PWHIV) who are in Insomnia frequently begins prior to the diagnosis of the advanced stages of the disease typically experience HIV,and it continues throughout the disease (Norman, very troubling symptoms.
    [Show full text]
  • Daytime Sleepiness
    Med Lav 2017; 108, 4: 260-266 DOI: 10.23749/mdl.v108i4.6497 Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA) Luigi Ferini-Strambi, Marco Sforza, Mattia Poletti, Federica Giarrusso, Andrea Galbiati IRCCS San Raffaele Scientific Institute, Department of Clinical Neurosciences and Università Vita-Salute San Raffaele, Milan, Italy KEY WORDS: Daytime sleepiness; Obstructive Sleep Apnea (OSA); hypersomnia PAROLE CHIAVE: Sonnolenza diurna; Apnee Ostruttive del Sonno (OSA); ipersonnia SUMMARY Excessive Daytime Sleepiness (EDS) is a common condition with a significant impact on quality of life and general health. A mild form of sleepiness can be associated with reduced reactivity and modest distractibility symptoms, but more severe symptomatic forms are characterized by an overwhelming and uncontrollable need to sleep, causing sud- den sleep attacks, amnesia and automatic behaviors. The prevalence in the general population is between 10 and 25%. Furthermore, EDS has been considered a core symptom of obstructive sleep apnea (OSA), as well as being the main symptom of primary hypersomnias such as narcolepsy types 1 and 2, and idiopathic hypersomnia. Moreover, it can be considered secondary to other sleep disorders (Restless Legs Syndrome, Chronic insomnia, Periodic Limb Movements), psychiatric conditions (Depression, Bipolar Disorder) or a consequence of the intake/abuse of drugs and/or substances. An accurate medical history cannot be sufficient for the differential diagnosis, therefore instrumental recordings by means of polysomnography and the Multiple Sleep Latency Test (MSLT) are mandatory for a correct diagnosis and treatment of the underlying cause of EDS. RIASSUNTO «Sonnolenza diurna: più di una semplice Apnea Ostruttiva nel Sonno (OSA)». L’eccessiva sonnolenza diurna (Excessive Daytime Sleepiness, EDS) è una condizione molto comune con un impatto significativo sulla qualità di vita e sulla salute in generale.
    [Show full text]
  • Case Report and Review of Literature on Hypersomnia As a Result of Stroke Pradeep C
    ISSN: 2638-1583 Madridge Journal of Neuroscience Case Report Open Access Sleepiness after Stroke: Case Report and Review of Literature on Hypersomnia as a Result of Stroke Pradeep C. Bollu1, Ashutosh Pandey2, Siva Prasad Pesala3 and Krishna Nalleballe1* 1Assistant Professor, Department of Neurology, University of Missouri, Columbia, USA 2Albert Einstein School of Medicine, Bronx NY, USA 3Neurologist, Department of Neurology, University of Missouri, Columbia, USA Article Info Keywords: Hypersomnia; Stroke; Daytime sleepiness; Conventional angiogram. *Corresponding author: Abbreviations: MRA: Magnetic resonance angiography; MRI: Magnetic resonance Krishna Nalleballe imaging; PLMS: Periodic limb movements in sleep; NREM: Non rapid eye movement; Assistant Professor SDB: Sleep disordered breathing Department of Neurology University of Missouri, Columbia 65212, USA Introduction Tel. 6032897308/5738821515 E-mail: [email protected] Daytime sleepiness is defined as the inability to stay awake and alert during the major waking episode of the day resulting in irrepressible need for sleep or unintended Received: March 16, 2017 lapses into drowsiness. Excessive sleepiness affects up to 5% of the general population Accepted: March 23, 2017 and can result in significant disability. Hypersomnia can be either the result of unmet Published: March 28, 2017 sleep needs or can also be due to reduced activity of alerting systems in the brain. The Citation: Bollu CP, Pandey A, Pesala SP, former can be due to sleep restriction or from sleep disruption. The International Nalleballe K. Sleepiness after Stroke: Case Classification of Sleep disorders categorize various disorders of hyper somnolence into Report and Review of Literature on Hypersomnia different sub-groups. Exaggerated sleep propensity with daytime sleepiness and/ or as a Result of Stroke.
    [Show full text]
  • Cognitive Behavioral Therapy for Insomnia Enhances Depression Outcome in Patients with Comorbid Major Depressive Disorder and Insomnia
    INSOMNIA AND DEPRESSION Cognitive Behavioral Therapy for Insomnia Enhances Depression Outcome in Patients with Comorbid Major Depressive Disorder and Insomnia Rachel Manber, PhD1; Jack D. Edinger, PhD2; Jenna L. Gress, BA1; Melanie G. San Pedro-Salcedo, MA1; Tracy F. Kuo, PhD1; Tasha Kalista, MA1 1Stanford University, Stanford, CA; 2VA Medical Center and Duke University Medical Center, Durham, NC Study Objective: Insomnia impacts the course of major depressive severity index (ISI), daily sleep diaries, and actigraphy. disorder (MDD), hinders response to treatment, and increases risk for EsCIT + CBTI resulted in a higher rate of remission of depression depressive relapse. This study is an initial evaluation of adding cogni- (61.5%) than EsCIT + CTRL (33.3%). EsCIT + CBTI was also associat- tive behavioral therapy for insomnia (CBTI) to the antidepressant medi- ed with a greater remission from insomnia (50.0%) than EsCIT + CTRL cation escitalopram (EsCIT) in individuals with both disorders. (7.7%) and larger improvement in all diary and actigraphy measures of Design and setting: A randomized, controlled, pilot study in a single sleep, except for total sleep time. academic medical center. Conclusion: This pilot study provides evidence that augmenting an Participants: 30 individuals (61% female, mean age 35±18) with MDD antidepressant medication with a brief, symptom focused, cognitive- and insomnia. behavioral therapy for insomnia is promising for individuals with MDD Interventions: EsCIT and 7 individual therapy sessions of CBTI or and comorbid insomnia in terms of alleviating both depression and in- CTRL (quasi-desensitization). somnia. Measurements and results: Depression was assessed with the Keywords: Major depressive disorder, Insomnia, Cognitive behavioral HRSD17 and the depression portion of the SCID, administered by raters therapy, Remission masked to treatment assignment, at baseline and after 2, 4, 6, 8, and Citation: Manber R; Edinger JD; Gress JL; San Pedro-Salcedo MG; 12 weeks of treatment.
    [Show full text]
  • Periodic Hypersomnia, Congenital Ectodermal Disorders and Multiple Exostosis
    PERIODIC HYPERSOMNIA, CONGENITAL ECTODERMAL DISORDERS AND MULTIPLE EXOSTOSIS RUBENS REIMÃO * — ARON DIAMENT ** SUMMARY — A case of periodic hypersomnia in an 11-year-old female with the unique features of mental deficiency, incontinentia pigmenti, acanthosis nigricans and hereditary multiple exostosis (diaphysial aclasis) is reported. The clinical, Polysomnographic and Multiple Sleep Latency test features of this case with a follow up of seven years are consistent with a diagnosis of periodic (intermittent) excessive somnolence. The unique presentation, however, does differ from Kleine-Levin syndrome and suggests a relationship between the predominantly ectodermal, congenital disorders and the sleep-wake, pattern dysfunction. Hipersônia periódica, malformações ectodérmicas e exostose múltipla. RESUMO — Relata-se um caso de sonolência excessiva periódica acompanhada de hiperfagia, com início na segunda década, documentado clinicamente, em tragados polissonográficos de noite inteira e no teste das Latências Múltiplas do Sono. Apresenta características que o distinguem da síndrome de Kleine-Levin, a saber, a ocorrência no sexo feminino, deficiência mental, incontinência pigmentar, acantose nigricans e exostose múltipla. There are two well defined syndromes of periodic hypersomnia!: menstrual cycle-related somnolence and the Kleine-Levin syndrome (KLS). The former is usually temporally linked with the menses; the latter, a rare condition, is generally limited to males in which the first episode of excessive sleepiness occurs in the second decade of life associated with hyperphagia. It supposedly results from hypothalamic or lymbic dysfunctions. This report describes a case of periodic hypersomnia and hyperphagia, beginning in the second decade but clearly distinct from KLS, occurring in a female with mental deficiency, incontinentia pigmenti and multiple exostosis.
    [Show full text]
  • Excessive Daytime Sleepiness and Unintended Sleep Episodes
    review article Oman Medical Journal [2015], Vol. 30, No. 1: 3–10 Excessive Daytime Sleepiness and Unintended Sleep Episodes Associated with Parkinson’s Disease Fatai Salawu1* and Abdulfatai Olokoba2 1Department of Medicine, Federal Medical Centre, Yola, Nigeria 2Department of General Internal Medicine, University of Ilorin Teaching Hospital, Ilorin. Nigeria ARTICLE INFO ABSTRACT Article history: This article looks at the issues of excessive daytime sleepiness and unintended sleep Received: 31 December 2012 episodes in patients with Parkinson’s disease (PD) and explores the reasons why patients Accepted: 7 December 2014 might suffer from these symptoms, and what steps could be taken to manage them. During the last decade, understanding of sleep/wake regulation has increased. Several brainstem Online: nuclei and their communication pathways in the ascending arousing system through the DOI 10.5001/omj.2015.02 hypothalamus and thalamus to the cortex play key roles in sleep disorders. Insomnia is Keywords: the most common sleep disorder in PD patients, and excessive daytime sleepiness is also Parkinson Disease; Sleep; common. Excessive daytime sleepiness affects up to 50% of PD patients and a growing Dopamine Agonists; body of research has established this sleep disturbance as a marker of preclinical and Pedunculopontine Nucleus. premotor PD. It is a frequent and highly persistent feature in PD, with multifactorial underlying pathophysiology. Both age and disease-related disturbances of sleep-wake regulation contribute to hypersomnia in PD. Treatment with dopamine agonists also contribute to excessive daytime sleepiness. Effective management of sleep disturbances and excessive daytime sleepiness can greatly improve the quality of life for patients with PD.
    [Show full text]
  • Original Articles
    ORIGINAL ARTICLES Improvement in Cataplexy and Daytime Somnolence in Narcoleptic Patients with Venlafaxine XR Administration Rafael J. Salin-Pascual, M.D., Ph.D. Narcoleptic patients have been treated with stimulants for sleep attacks as well as day- time somnolence, without effects on cataplexy, while this symptoms has been treated with antidepressants, that do not improve daytime somnolence or sleep attacks. Venlafaxine inhibits the reuptake of norepinephrine, serotonin, and to lesser extent dopamine, and also suppressed REM sleep. Because some of the symptoms of nar- colepsy may be related to REM sleep deregulation, venlafaxine was studied in this sleep disorder. Six narcoleptic patients were studied, they were drug-free and all of them had daytime somnolence and cataplexy attacks. They underwent the following sleep proce- dure: one acclimatization night, one baseline night, followed by multiple sleep latency test. After two days of the sleep protocol, patients received 150 mg of venlafaxine XR at 08:00 h. Two venlafaxine sleep nights recordings were performed. Patients were fol- lowed for two months with weekly visits for clinical evaluation. Sleep log and analog- visual scale for alertness and somnolence were performed on each visit. Venlafaxine XR was increase by the end of the first month to 300 mg/day. Sleep recordings showed that during venlafaxine XR two days acute administration the following findings: increase in wake time and sleep stage 1, while REM sleep time was reduced. No changes were observed in the rest of sleep architecture variables. Cataplexy attacks were reduced since the first week of venlafaxine administration. Daytime somnolence was reduced also, but until the 7th week and with 300 mg/day of venlafaxine XR administration.
    [Show full text]
  • Sleep Disorders in General Last Updated: May 8, 2019 CLASSIFICATION
    SLEEP DISORDERS (GENERAL) S40 (1) Sleep Disorders in General Last updated: May 8, 2019 CLASSIFICATION ...................................................................................................................................... 1 ETIOLOGY ................................................................................................................................................ 3 DIAGNOSIS................................................................................................................................................ 3 TREATMENT ............................................................................................................................................. 5 10-15% of population have sleep-related problems! CLASSIFICATION International Classification of Sleep Disorders: 1. Dyssomnias - sleep disorders that result in: 1) insomnia (perceived inability to obtain sufficient sleep) 2) excessive daytime somnolence (excessive sleepiness or fatigue during day) 2. Parasomnias - undesirable physical & mental phenomena that occur during sleep - disorders of arousal / partial arousal / sleep stage transition. 3. Sleep disorders associated with: a) psychiatric disorders (esp. depression and anxiety) – sleep disturbance may be first or most significant symptom! b) medical disorders (e.g. awakening by pain, respiratory difficulty due to asthma, urge to urinate, etc). c) neurodegenerative disorders: o neuronal systems involved in sleep-wake regulation; o neuronal systems involved with regulation of breathing during
    [Show full text]
  • Excessive Daytime Sleepiness in Patients with Myasthenia Gravis
    Journal of Neuromuscular Diseases 2 (2015) 93–97 93 DOI 10.3233/JND-140057 IOS Press Research Report Excessive Daytime Sleepiness in Patients with Myasthenia Gravis C.D. Kassardjiana, S. Kokokyib, C. Barnetta,b, D. Jewellc, V. Brila,b, B.J. Murraya,c and H.D. Katzberga,b,∗ aDivision of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada bUniversity Health Network, Toronto, ON, Canada cSunnybrook Health Sciences Centre, Toronto, ON, Canada Abstract. Excessive daytime sleepiness (EDS) has not been investigated using objective tests in myasthenia gravis (MG). We investigated whether objective measurements of somnolence better detected abnormalities compared with sleepiness question- naires in MG, and determine if MG patients have EDS. Eight patients with mild-to-moderate MG were recruited. Patients completed maintenance of wakefulness, overnight polysomnography, multiple sleep latency tests, Epworth Sleepiness Scale, and fatigue questionnaires. Seven patients demonstrated EDS on objective testing, while Epworth scores were abnormal in two, and the measures showed poor correlation. Our findings highlight that the ESS may be inadequate to diagnose EDS and lead to under-reporting of daytime somnolence in patients with MG. Keywords: Myasthenia gravis, sleep, excessive daytime sleepiness, sleep apnea INTRODUCTION There are no studies quantifying increased sleep tendency in MG using objective measures in a sleep Myasthenia gravis (MG) is an autoimmune disorder laboratory. The aim of this study was to investigate of the neuromuscular junction characterized by fati- whether objective measurements of increased sleep gable weakness. Patients with MG often complain of tendency correlate with subjective sleepiness question- non-restful sleep and daytime somnolence. Studies of naires, and reliably detect somnolence in MG.
    [Show full text]
  • Sleep-Wake Complaints and Their Relation to Sleep Disturbance
    Henry Ford Hospital Medical Journal Volume 36 Number 1 Article 4 3-1988 Sleep-Wake Complaints and Their Relation to Sleep Disturbance De Ton Frank J. Zorick Timothy A. Roehrs Robert M. Wittig Jeanne M. Sicklesteel See next page for additional authors Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Ton, De; Zorick, Frank J.; Roehrs, Timothy A.; Wittig, Robert M.; Sicklesteel, Jeanne M.; and Roth, Thomas (1988) "Sleep-Wake Complaints and Their Relation to Sleep Disturbance," Henry Ford Hospital Medical Journal : Vol. 36 : No. 1 , 9-12. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol36/iss1/4 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. Sleep-Wake Complaints and Their Relation to Sleep Disturbance Authors De Ton, Frank J. Zorick, Timothy A. Roehrs, Robert M. Wittig, Jeanne M. Sicklesteel, and Thomas Roth This article is available in Henry Ford Hospital Medical Journal: https://scholarlycommons.henryford.com/ hfhmedjournal/vol36/iss1/4 Sleep-Wake Complaints and Their Relation to Sleep Disturbance De Ton, MD,* Frank J. Zorick, MD,^ Timothy A. Roehrs, PhD,^ Robert M. Wittig, MD,' Jeanne M. Sicklesteel, BA,^ and Thomas Roth, PhD+ This report is a comparison of patients presenting with 1) an insomnia complainl diagnosed as no objective findings. 2) insomnia diagnosed as being associated with a psychiatric disorder, and 3) daytime sleepiness diagnosed as no objective findings.
    [Show full text]
  • SUPPLEMENTARY MATERIAL Complete Database Searches
    Manuscript title: A systematic review of instruments for the assessment of insomnia and sleep hygiene practices among adults SUPPLEMENTARY MATERIAL Complete database searches: 1. PubMed (1966-April 2018) Date Results Limitations Results after Combination of terms used limitation 28/3 (sleep disorders AND 3786 Observational studies, 99 insomnia*) AND (Instrument validation studies OR questionnaire OR measure human studies OR scale) English Arabic Adults (19-65+) 28/3 (Insomnia OR sleep 6387 Validation studies 148 deprivation) AND (Instrument Observational studies OR subjective measure OR Human questionnaire) English Arabic Adults (19-65+) 7/4 (sleep quality OR dyssomnias 23529 Validation studies 394 OR daytime sleepiness) AND Human (instrument OR questionnaire English OR scale) Arabic Adults (19-65+) (Sleep hygiene OR sleep 3258 Validation studies 40 7/4 habits OR sleep practices) Observational studies AND (Instrument OR Human questionnaire OR measure*) English Arabic Adults (19-65+) (("sleep arousal disorders" OR 15989 Validation studies 135 28/3 "sleep disturbance") AND Human insomnia* OR sleepiness) English Manuscript title: A systematic review of instruments for the assessment of insomnia and sleep hygiene practices among adults AND (Instrument OR Arabic questionnaire OR scale OR Adults (19-65+) measure) ("sleep efficiency" OR "sleep 1480 Validation studies 41 7/4 dissatisfaction") AND Observational studies (Instrument OR questionnaire Human OR scale OR measure) English Arabic Adults (19-65+) 7("sleep disorders" OR " sleep 451 No study limits 320 7quality" OR " sleep deprivation" 7/4 / OR "sleepiness" OR " Human 4insomnia" OR "sleep English / dysfunction" OR "dyssomnias" Arabic 4OR "sleep arousal disorders") Adults (19-65+) 2AND (instrument OR tool OR 9scale OR questionnaire OR survey OR "patient-reported outcomes") AND ("validation studies" OR "psychometric properties") Total number of articles = 1,197 Manuscript title: A systematic review of instruments for the assessment of insomnia and sleep hygiene practices among adults 2.
    [Show full text]
  • Drug-Induced Sleepiness and Insomnia: an Update Sonolência E Insônia Causadas Por Drogas: Artigo De Atualização
    36 Drug-induced sleepiness UPDATE ARTICLE Drug-induced sleepiness and insomnia: an update Sonolência e insônia causadas por drogas: artigo de atualização Renato Gonçalves1, Sonia Maria Guimarães Togeiro2 ABSTRACT doctor’s task is more complex as more comorbid conditions are Medical practice of sleep medicine requires an extensive found in these patients, which makes patient evaluation more pharmacological knowledge, especially when you need to make difficult and intriguing. decisions about the drug scheme already adopted by a given In this update, we focus on the potential for sedation patient. The care of patients with multiple diseases and using of or insomnia of drugs used in the most common chronic multiple drugs has become common. The great challenge facing the physician is to what extent one or more drugs may be contributing diseases worldwide. Doctors often treat patients with multiple to the complaint of sleepiness or insomnia. Any drug with activity comorbidities. It is estimated that 25% of the population of in the central nervous system has the potential to affect sleep-wake North America presents more than one chronic disease(1). cycle. The pharmacokinetic drug knowledge’s will be useful in Among the more prevalent chronic diseases across the world are determining the likelihood of adverse effects on sleep-wake functioning. In this article we describe the potential sedative or in cardiovascular diseases (systemic hypertension, congestive heart generating insomnia by drugs used in the major chronic diseases in failure, and coronary insufficiency), diabetes mellitus, chronic the population. obstructive pulmonary diseases, arthritis, depression, and cere- Keywords: conscious sedation, drugs, hypersomnia, sleep, sleep brovascular accident(2).
    [Show full text]